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Executive Summary 
Exploring pathways in the diagnosis and treatment of breast problems in the 
hospital setting. 
 
Reference Number:  RDF 032 
 
      Start date: 01.09.1997 
      End date:   31.12.2000 
 
Research Training Fellow 
      Hilary Bungay 
      Kent and Canterbury Hospital Trust 
      Based at The Centre for Health Services Studies University of Kent at Canterbury. 
 
Research Training 
Attended the post-graduate research Training course at the University of Kent which included     
the following modules: Introduction to the Philosophy of Social Sciences, Using Secondary 
Sources, Introduction to Quantitative Analysis, Introduction to Qualitative Analysis, and 
Presenting Results. I have also attended the following day courses organised by the University of 
Surrey: Qualitative Interviewing, Discourse Analysis and an Introduction to the use of Atlas-ti.    
 
Main Research Questions: 
Do delays occur in the hospital phase of the diagnosis and treatment of breast cancer, and if so 
why do they occur and do they matter? 
 
The Aims and Objectives of the Study 
Aim: 
To follow patient pathways, patterns of treatment, and the sources and extent of any delays in the 
treatment of breast cancer within a hospital environment. 
 
Objectives:  
x To identify the length of time between the sending of the referral letter by the GP and the 
patients first attendance at the outpatients department (phase 1). 
x To identify the length of time between the patients first attendance and the confirmation of 
diagnosis, whether positive or negative (phase 2). 
x To identify the length of time between the confirmation of diagnosis and either the start of 
specialist treatment where indicated or discharge (phase 3). 
x To explain variations in the length of time taken for each of the above stages. 
x To assess the significance of delay in terms of patient satisfaction and clinical outcome. 
 
Methodology and Sample Size 
The study used a combination of qualitative and quantitative methodologies to explore variations 
in the provision of services for the diagnosis and treatment of breast cancer. In order to study 
variation in process it was necessary to look at a number of sites and three hospitals in the NHS 
South Thames region were selected on the basis of the facilities they provided. A quantitative 
survey of a total of 100 women in each of the hospital sites was carried out to study the pathways 
that women with breast symptoms take and to measure the length of each stage of the process. 
The data was collected prospectively through structured observation which allowed the 
interactions within the clinics to be observed. To determine the perceptions of the process from 
WKHVWDIIDQGWKHSDWLHQWV¶YLHZSRLQWVDVHULHVRIVHPL-structured interviews were undertaken. A 
total of 19 interviews with staff and 37 interviews were conducted, these interviews were taped, 
transcribed and then analysed using Atlas-ti.   
 
Problems 
The main problem encountered during the study was obtaining access to one of the research sites. 
Firstly in making contact with the lead clinician responsible for the breast clinic. Secondly, 
making contact with the administrator for the Local Research Ethics Committee (LREC) to get an 
application form. The application form for the LREC was then changed and a further different 
form was completed, the LREC also then required all applications to go through their Research 
and Development Office before consideration. Finally once the application was submitted the 
LREC requested some additional information before granting ethical approval. Other problems 
included the slow recruitment of patients to be interviewed, and the difficulty of learning how to 
use two computer programs, SPSS and Atlas-ti in order to analyse the data.  
 
Findings  
x One stop clinics potentially provide patients with a diagnosis in the shortest possible time. 
x Where prioritising of referral letters occurs, it appears to cause patients who are referred 
routinely to wait longer for appointments than at sites where prioritising is less rigorously 
applied. 
x Variations in the process of care between sites appear linked to the availability of imaging 
facilities and the number of patients who can be imaged per clinic session. 
x Waiting for results during the diagnostic phase is a stressful time for patients. 
 
Conclusions 
Variations in the process of care between sites appear to be linked to the availability of imaging 
facilities and the staff. It is apparent from both observation and from interviews with the staff that 
there is a shortage of radiologists specialising in breast imaging with a need for more 
professionals competent to perform breast ultrasound and image guided procedures. Further study 
may be useful to look at an alternative skill mix to facilitate the speedy diagnosis of breast 
cancers.  
A further area of delay high-lighted in this study is in the discharging of patients; the 
implementation of guidelines may help to lessen the number of follow up appointments and so 
reduce the large number of patients in follow up clinics and the increased anxiety caused by 
further attendance in the clinic. 
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Main Report 
1. Title:   Exploring pathways in the diagnosis and treatment of breast problems in the  
hospital setting. 
 
      Reference Number:  RDF 032 
 
      Start date: 01.09.1997 
      End date:   31.12.2000 
 
2.  Research Training Fellow 
     Hilary Bungay 
     Kent and Canterbury Hospital Trust 
     Supervisor from September 1997 to August 2000 Professor M.W. Calnan 
     Supervisor from September 2000 to present Professor J. Butler 
     Centre for Health Services Studies University of Kent at Canterbury 
 
3. Research Training 
Attended the post-graduate research Training course at the University of Kent which 
included the following modules: Introduction to the Philosophy of Social Sciences, Using 
Secondary Sources, Introduction to Quantitative Analysis, Introduction to Qualitative 
Analysis, and Presenting Results. I have also attended the following day courses 
organised by the University of Surrey: Qualitative Interviewing, Discourse Analysis and 
an Introduction to the use of Atlas-ti.    
 
4. Main Research Questions: 
Do delays occur in the hospital phase of the diagnosis and treatment of breast cancer, and 
if so why do they occur and do they matter? 
  
The Aims and Objectives of the Study 
Aim: 
To follow patient pathways, patterns of treatment, and the sources and extent of any 
delays in the treatment of breast cancer within a hospital environment. 
 
Objectives:  
x To identify the length of time between the sending of the referral letter by the GP and 
WKHSDWLHQW¶VILUVWDWWHQGDQFHDWWKHRXWSDWLHQWVGHSDUWPHQWSKDVH). 
x 7R LGHQWLI\ WKH OHQJWK RI WLPH EHWZHHQ WKH SDWLHQW¶V ILUVW DWWHQGDQFH DQG WKH
confirmation of diagnosis, whether positive or negative (phase 2). 
x To identify the length of time between the confirmation of diagnosis and either the 
start of specialist treatment where indicated or discharge (phase 3). 
x To explain variations in the length of time taken for each of the above stages. 
x To assess the significance of delay in terms of patient satisfaction and clinical 
outcome. 
 
5.   Background 
After the introduction of the National Breast Screening Programme (NHS BSP), there 
were two ways in which services for women with breast cancer were delivered. A woman 
with a screen-detected cancer in a NHS BSP unit would receive treatment from a 
specialist team in a unit with an audited system of quality control that adhered to national 
guidelines and protocols (House of Commons Health Committee 1995). However no 
such structure was in place for women who were symptomatic, and there was a wide gulf 
between best and worst practices. In the best scenario a woman could be seen by her 
General Practitioner (GP), referred to a specialist breast clinic and receive all the 
diagnostic tests necessary to be assured she was not suffering from breast cancer at one 
visit.  On the other hand she could be referred to a non-specialist general surgical clinic, 
wait months for an appointment, be referred for a mammogram, be seen by junior staff 
and finally receive an inappropriate operation (British Association of Surgical Oncology 
1995). Concern was expressed over the variations in the provision and quality of services 
for breast cancer as evidence emerged that survival from breast cancer was linked to the 
locality in which the patient lived and the nature of services provided (Sainsbury 1995). 
 
Guidelines for the diagnosis and treatment of breast cancer were published in 1996 by the 
Cancer Guidance Sub-group of the Clinical Outcomes Group (Cancer Guidance Sub-
group 1996). These, along with guidelines from the British Association of Surgical 
Oncologists (1995), laid down standards of care which included recommended time 
intervals between each stage of the process from referral by the GP to the diagnosis and 
subsequent treatment of the disease.  Although there was no evidence at that time that a 
short delay would effect clinical outcome, it was recognised that delays of more than six 
PRQWKV EHWZHHQ D SDWLHQW¶V ILUVW DZDUHQHVV RI V\PSWRP DQG WUHDWPHQW ZHUH DVVRFLDWHG
with poorer survival outcomes (Cancer Guidance Sub-group 1996). There was concern 
therefore that delay should be minimised, at the several points where it can occur. The 
patient may delay or postpone presenting a symptom to the GP; the GP may delay or 
postpone referring the patient to the hospital; and there can be a hospital delay in 
assessing the patient and in commencing treatment.  
 
The time taken between the presentation of symptoms to the GP and specialist assessment 
DQGWUHDWPHQWZKHUHDSSURSULDWHKDVEHHQGHILQHGDVµV\VWHPGHOD\¶1RVDUWLHWDO
There is however some ambiguity in the definition of delay. Who, for example, decides 
what is an acceptable time to wait for an appointment? What constitutes a delay? And 
how significant is that delay? Although there is no evidence to suggest that a short delay 
will effect clinical outcome, Facione (1993) found evidence that a third of women with 
breast cancer symptoms delayed seeking help for three months or more. And yet the need 
for speed in the initial referral to a hospital and in the establishment of a diagnosis was 
considered an absolute necessity by virtually all the patients taking part in the study 
µ3DWLHQW-&HQWUHG &DQFHU 6HUYLFHV"¶ 1DWLRQDO &DQFHU $OOLDQFH  6R DOWKRXJK
patients may delay seeking help, once that initial contact is made, it is important to 
receive the diagnosis and the appropriate treatment as soon as possible. 
   
The prevention of delay in the diagnosis and treatment of all types of cancer is now 
firmly on the policy agenda.  The National Cancer Plan (Department of Health 2000) 
stressed the need for faster access to treatment with new targets to reduce waiting at all 
stages of the pathway of care. In the case of breast cancer since April 1999 all patients 
with a suspected breast cancer are supposed to be seen by a specialist within two weeks 
of an urgent referral from their GP (Health Service Circular (HSC) 1998/242). The 
National Cancer Plan stated that by 2001 there would be a maximum wait of one month 
from diagnosis to treatment for breast cancer, and also that guidelines would be laid down 
to end what iWFDOOHGWKHµSRVWFRGHORWWHU\RIFDUH¶ZKHUHSHRSOHLQGLIIHUHQWSDUWVRIWKH
country received varying quality and types of treatment. 
 
In light of this, the purpose of this study is to examine what happens to patients once they 
are referred to the hospital with breast symptoms and to compare such pathways between 
different hospital settings (looking at the time taken for each part of the process) in order 
to determine the extent and nature of any variations in the process of care (which may in 
turn explaLQDQ\GHOD\V7KHµSURFHVVRIFDUH¶LQFOXGHVQRWRQO\WKHPHWKRGRIGLDJQRVLV
the treatment route and the urgency with which each individual case is dealt but also the 
social interactions which take place within the clinic, and between the clinic and the rest 
of the hospital.  
 
 
6.  Methodology 
 
6.1    Choice of Methods 
The complex nature of this research question did not favour either a purely quantitative or 
qualitative methodology and therefore a combined methodology was adopted. In order to 
study the pathways that women with breast symptoms take and to measure the length of 
each stage of the process, a quantitative survey was carried out. Any variations in process 
within sites and between sites would therefore be quantified and possible causal 
relationships identified. However from an epistemological position qualitative research is 
the most appropriate method to explore how complex social processes and organisations 
operate. Therefore the survey data was collated through structured observations which 
allowed the interactions within the clinics to be seen. To determine the perceptions of the 
SURFHVVIURPWKHVWDIIDQGWKHSDWLHQWV¶YLHZSRLQWVDVHULHVRIVHPL-structured interviews 
were undertaken. The study is exploratory and attempts to develop a theory about the 
possible influences on the variations experienced by women in the hospital process.  
 
 6.2   Selection of Sites 
Since the study aimed to explore variations in the provision of services for the diagnosis 
and treatment of cancer it was necessary to look at a number of sites. The sites were 
chosen purposively on the basis of different organisational characteristics and the 
facilities they provided for cancer services. The reason for adopting this approach was 
that different organisational characteristics, in terms of the level of provision of services, 
were expected to affect what happens to patients. The sites were chosen to reflect the 
national pattern, and because of the available resources only one of each type was 
studied: 
 
1. A District General +RVSLWDO'*+ZLWKDµRQHVWRS¶EUHDVWFOLQLFEXWZLWKRXWD1+6
BSP assessment Unit and a cancer unit with no radiotherapy facilities on site (Site A) 
2. $'*+ZLWK D µUDSLG DFFHVV¶EUHDVW FOLQLF DQGD1+6%63DVVHVVPHQWXQLW DQGD
cancer centre  with radiotherapy facilities on site (Site B) 
3. A London teaching hospital which acts as a tertiary referral centre with a NHS BSP 
assessment Unit and training centre, no Radiotherapy facilities on site. (Site C) 
 
6.3  Sample Size  
The quantitative survey involved a total of one hundred women in each of the three 
different hospital sites. This sample size was determined with the assistance of a 
statistician using the computer package MINITAB and was based on the number of 
patients seen at each of the sites per annum, and the proportion of these who had a 
positive diagnosis. These were 1:10, 1:7 and 1:15 (Macmillan Directory of Breast Cancer 
Services in the UK 1996). To simplify the calculation 1:10 was chosen rather than the 
mean of the three sites (1:11). The primary end-point for those with breast cancer is the 
commencement of treatment whether this is surgery or neo-adjuvant chemotherapy; for 
those with a negative diagnosis it is the date of discharge. It was felt that a difference of 
more than seven days at the primary end point between centres would be significant, and 
a sigma of 6 was used because it was felt that the end point for most women within each 
site group would fall within a narrow range. Using these figures a sample size of 100 
women at each site (a total of 300 women) would allow comparison between the groups 
at a power of 80% and a significance of 5%. 
 
6.4  Sampling 
The sample was stratified by clinician to allow the data to be collected during the 
observation of the clinic. Each week a different clinician was observed, and all the 
patients seen by that doctor were included in the sample. Selection bias was avoided  
because the clinic lists were determined a number of weeks in advance and the doctor 
selected randomly at each clinic.  
 
 6.5  Interviews 
Semi-structured interviews were conducted with a number of staff on each site, selected 
on the basis of their roles within clinic which had been determined during the 
REVHUYDWLRQDO SKDVH 7R JDLQ LQVLJKW LQWR WKH SDWLHQWV¶ H[SHULHQFHV RI WKH FOLQLFV VHPL-
structured interviews were conducted with a sample of 10-15 women from each clinic 
and a method of quota sampling was used to obtain this sample. It had originally been 
proposed that interviews would take place only with women who had a positive diagnosis 
of breast cancer. During the pilot work however, it became evident that the majority of 
women attending the clinics would have a normal diagnosis and that their views of the 
process should also be considered. Quota sampling was used to avoid those women 
newly diagnosed with breast cancer being approached at a time of great distress. Women 
were selected on the basis of having had a negative diagnosis or a positive diagnosis in 







  7.     Project Plan and Timetable 
 
 September 1997       Start of Fellowship 
x Literature Review- The development of the cancer services 
 
 March 1998         6 month report 
x Literature Review- Delay in the diagnosis and treatment of cancer 
x Development of a conceptual framework 
x Field Work Planning 
 
 September 1998    12 month report 
x Development of Methodology  
x Setting up of Pre-pilot Work 
x Work for upgrading process from MPhil to PhD 
x Attended research training programme 
 
  March 1999     18 month report 
x Pilot Work at 1st research site 
x Ethical approval from 1st research site 
x Upgrading seminar 
x Contact with 2nd research site 
 
  September 1999   24 month report 
x Data collection commenced at site 1 
x Ethical approval obtained from site 2 
x Data collection started at site 2 
x Contact with site 3 
x Ethical approved from site 3 
  
  March 2000      30 month report 
x Quantitative data collection at sites 1 and 2 completed 
x Interviewing at these sites on-going    
x Applied for extension to Fellowship because of problems with communication and 
the 3rd site delayed start of data collection by 4 months.   
x Data collection started at site 3  
x Presented preliminary findings to British Sociological Association annual conference 
x Analysis of data 
   
  September 2000    Extension period 
x Completed data collection 
x Analysis of data 




 8. Results and Findings 
 
Findings Part 1- Observational Data 
Site Characteristics 
To provide information on some of the features of the sites, the table below shows the 
main characteristics in terms of space, staff and numbers of patients seen each week. In 
the appendix 1 there are flow charts which show the patient pathways at each site. 
  
Features Site A Site B Site C 
Type of Clinic One Stop ±mainly 
new patients 
Multidisciplinary- 
and follow up 
patients also seen 
Rapid Access ±new 
patients only 
 
Location Oncology Suite  Main Outpatients Designated Breast 
Unit 
Number of clinics 
for new patients per 
week 
1 1 2 
Number of new 
patients per week 
34 (plus 8-15 follow 
ups) 
21  (plus 50-60 
follow ups) 
45-50 
Number of  
surgeons 
2 2 2 (1 only present in 
one clinic) 
Other doctors in 
clinic 
2  (Hospital  
Practitioners) 
3 (Breast Physician, 
Registrar, SHO) 
2 (Registrar, SHO) 
Nursing staff 4 4 0 
Breast care nurses  2 2 1 





 Findings Part 2- Survey Data 
Introduction  
For each woman or case the following data was collected:  
x 7KHZRPDQ¶VKRVSLWDOQXPEHUWRDOORZIROORZ-up of subsequent visits. 
x The affected side whether right or left or both breasts are involved. 
x The date of birth, to allow calculation of age at date of attendance. 
x The presenting symptom, 
x A family history of breast cancer, 
x The use of Hormone Replacement Therapy, 
x Mode of referral (letter or fax). 
x Date of referral by GP 
x Date of receipt of referral 
x Date of attendance(s). 
x The investigations undertaken (with dates) and the results of the investigations, 
x Where appropriate details of surgery, date and type, chemotherapy, and radiotherapy. 
  
Characteristics of the total sample. 
From the sample at each site the numbers receiving a positive diagnosis were site A - 9, 
site B - 12 and site C- 7, giving ratios of positive to negative of 1:10, 1:7  and 1:13 
respectively. These compared favourably with the findings of the Macmillan Directory 
(1996) and suggest that the sample was representative of each site. In addition the age 
range and the symptoms experienced by the samples from each site were similar as 
shown in the graphs below indicating that differences occurring in the process of care 



















Where do Delays Happen?  
Referral to Attendance (Phase 1) 
Figure 1 (Appendix 2) shows the distribution of the total sample in days, and 75% of all 
women are seen within 21 days of referral. Government guidelines direct that all women 
with breast symptoms indicative of cancer should be seen within 14 days of referral by 
the GP. Looking at Figures 2, 3, and 4, all three sites maQDJHGWRDFKLHYHWKHµWZRZHHN¶
wait in the majority of the urgent referrals. For the sample as a whole (routine and urgent 
referrals), patients at site B were seen in a median time of 9 days (range 0-27) and 92.9% 
were seen within 21 days of referral. Sites A and C had patients waiting longer for the 
first appointment, with a median time of 15 days (range 5-81) at site A with 24% waiting 
longer than 21 days, and at site C there was a median time of 21 days (range 1-77) with 
45% of patients waiting for longer than 21 days. 
 
Time from Attendance to Confirmation of Diagnosis (Phase 2) 
The point of measurement for the confirmation of diagnosis was a complex one. This is 
because, particularly at Sites B and C, it was not always possible to know the exact day 
when patients received their diagnosis because the results were sent either to the GP or 
directly to the patient. Therefore for consistency, the date of diagnosis was taken to be the 
date that the definitive results of the investigations were known by the hospital. From the 
graphs (figs 5-8) it can be observed that although Site B assessed their patients in the 




































lump w ith pain
shortest time, once seen by the doctor patients waited significantly longer to receive a 
diagnosis than at the other two sites. Indeed the median time from attendance to diagnosis 
at site B was 21.5 days compared to 0 days at sites A & C. 80% of patients at site A 
received a diagnosis on their first visit, and at site C 72% received a diagnosis at the first 
visit, and in 95% of the patients a diagnosis was known within 7 days of attendance.  
 
Confirmation of Diagnosis and Appropriate Action (Phase 3) Figures 9-12 
From the graph for the total sample (fig 9) it can be noted that over a third of the patients 
either are discharged or start appropriate treatment at the first visit. The primary endpoint 
for those patients with a negative diagnosis is the date of discharge and it was felt that a 
difference of more than 7 days between the sites would be significant. The mean time for 
confirmation of a negative diagnosis and discharge at site A was 32.6 days for site B 9.7 
days and for site C 5.4 days (the median time was 42, 0, 0, respectively) there was 
therefore a significant difference between site A and the other two sites.  
 
The primary endpoint for those with a positive diagnosis was the start of appropriate 
treatment and the median times for these were site A 8 days, site B 5 days and site C 20 
days. There was a difference of more than 7 days between site C and the other two sites 
which is significant however because the numbers in the sample are small it may be more 
meaningful to perform case matched studies (matched by age) between the sites.  
 
Why do Delays Happen? 
Introduction 
Delay is an arbitrary term with no recognised point or time after which delay can be said 
to have occurred. However in this study it is assumed that a delay occurred if the best or 
shortest time was not achieved for all. There were differences not only between the sites 
but also within the sites as demonstrated by Figures 1-12. The variations that occurred in 
the process may explain the differences in the length of each phase that are apparent 
between the sites and within the sites. Nolan and Provost (1990) suggested that variations 
in process could have two types of causes: common causes that are inherently part of the 
process, and special causes that are not part of the process all the time but arise because 
of specific circumstances. For example in a breast clinic common causes would be factors 
such as the appointment system, the number of staff and number of clinics per week, and 
special causes would be staff holidays, patients not attending for appointments, or referral 
letters being lost. 
 
Referral to Attendance (Phase 1) 
:KHUHWKHµWZRZHHN¶ZDLWZDVQRWDFKLHYHGLWZDVQRWLQWKH most part due to failure of 
the clinic to book appointments appropriately but was mainly caused by special 
circumstances such as; incorrect referral, failure of post, and patients already in hospital 
with other conditions. Looking at variations between the sites for the sample as a whole 
(routine and urgent cases), at site B patients were seen in the shortest time; this may be 
attributed to there being no prioritising of letters by the staff and patients being slotted 
into the first available clinic space. At sites A and C, there appears to be a wide 
distribution of waiting times with some patients waiting for more than 6 weeks; this could 
be due to the prioritising of referrals and the fact that clinic numbers were limited by the 
number of patients who could be imaged in the clinic time. Some patients who appeared 
to have been delayed had failed to attend first and even second appointments or had 
cancelled appointments. Other patients who had waited were patients with vague breast 
pain or were concerned about their family history. 
 
Attendance to Confirmation of Diagnosis (Phase 2) 
Site A operated the one stop clinic that provided the means for diagnosis at one visit. 
However if further ultrasound examinations were required, these were booked before the 
six week follow up appointment. Site B had the facility to image only one or two patients 
considered urgent on the day of the clinic. The variations that occurred within this site 
were due to the prioritising for imaging that the surgeons operated and are shown in the 
patient pathway chart in the appendix. Variation in the length of time to diagnosis 
compared to the other sites would be expected because of the imaging facilities that were 
commonly available. There were also special causes that may have produced a greater 
than expected variation between site B and the other sites. Firstly, the data collection at 
this site spanned the Christmas holiday season and secondly, the radiologist who 
performed the ultrasound examinations was on leave during this time.  
Although at Site C patients waited the longest time for the first appointment, once 
assessed, 97% had a diagnosis within 14 days of attendance. Where patients waited 
longer than this was due to patients waiting for investigations in equivocal conditions. 
 
Confirmation of Diagnosis to the Start of Treatment or Discharge where 
Appropriate. (Phase 3). 
Looking at variations within the sites, at site A, the discharge date/start of appropriate 
treatment was only recorded for 69 cases. This was a result of the number of patients who 
were still being reviewed when the data collection period ended. The reason for this 
appears to be that one of the surgeons was very cautious in discharging patients and 
reviewed them a number of times before discharging them. At site B almost half the 
sample were discharged on the first attendance, either without investigation or referred 
back to the GP and so effectively discharged from the hospital. The most common cause 
of delay in discharge for those with a negative diagnosis was waiting for a follow up 
appointment post imaging. The patient who waited longest at site C for the start of 
appropriate treatment was a woman with a positive diagnosis who required further 
investigations for the staging of her disease prior to surgery. Patients can be discharged at 
first attendance without any imaging, or they may be discharged by the radiologist after 
imaging. Results may go to the GP or be sent directly to the patient; such methods of 
discharge avoid delays caused by waiting for follow up appointments. 
 
Do these delays matter? 
From the data it can be seen that there were evident differences in the process of care at 
each site. At one of the sites patients routinely waited longer for the first appointment but 
once in the system received their diagnosis quickly and were discharged. At another site 
the patients were routinely seen quickly and had all the investigations necessary for a 
diagnosis at the first visit, but were then routinely followed up on a regular basis. And at 
the last site patients were rapidly assessed by the surgeon as to whether further 
investigation was required but then waited for imaging and again for a post imaging 
appointment to receive the diagnosis. Are these differences important and do they matter? 




It was generally agreed by the staff that there was no clinical reason why two weeks had 
been chosen rather than a different time scale and that whilst it made no difference 
clinically to the outcome for the patient, it could have a psychological impact. 
 
³,W GRHVQ¶W PDNH DQ\ GLIIHUHQFH DW WKH HQG RI WKH GD\ )URP WKHLU GLVHDVH LW
GRHVQ¶WPDNHDGLIIHUHQFH)URPWKHSV\FKRORJLFDODVSHFWVLWVQHYHUWUXO\EHHQPHDVXUHG
,I\RX¶UHVHHQZLWKLQWZRZHHNV of the guidelines for some patients that may be lovely and 
WKH\IHHOUHDVVXUHGDERXWWKDWRWKHUSHRSOHPLJKWEHTXLWHFRQFHUQHGDQGWKLQNRK,¶YH
JRWFDQFHURUVRPHWKLQJVHULRXVEHFDXVHRIWKHWLPHVFDOH´(Breast Care Nurse) 
                                                                         
However it was also pointed out that recent literature had suggested that a delay of 3-6 
months could affect survival and that that delay could be accumulative. 
 
³:KHQ\RXDGGRQWKHSDWLHQWVGHOD\DQGWKHJHQHUal practitioners delay and the delay 
JHWWLQJLQWRKRVSLWDOPRQWKVJRHVE\YHU\TXLFNO\´(Clinician) 
 
From the patients perspective waiting any length of time can be difficult as this quote 
from a woman who waited two weeks for her appointment demonstrates. 
 
³,NHSWWKLQNLQJDOOWKHWLPH\RXNQRZZKHQWKH\VDLGLWZRXOGEHWKDWOHQJWK
and I thought oh good grief and every day it was on my mind, every time I woke up, I 
would wake up in the night and I would think about it constantly, it would never go away, 
LWZDVFRQVWDQWO\RQP\PLQG´:RPDQLQ¶VZLWKQHJDWLYHGLDJQRVLV  
 
Waiting for appointments 
Waiting 5 days or 14 days for a specialist assessment may not have an impact on the 
eventual outcome in terms of survival. However, the waiting time or the perception of the 
waiting time for an appointment may be influenced by expectation, for example of what 
is felt to be an acceptable time to wait for an appointment, and local knowledge of the 
hospital system. A further factor is uncertainty as to the outcome of the consultation; 
women reported that their anxiety increased the longer they waited and it appeared that 
some of this anxiety stemmed from their beliefs about cancer. 
 
³, WKLQN DQ\WKLQJ WR GR ZLWK \RXU RZQ KHDOWK WKDW \RX¶UH FRQFHUQHG DERXW \RX 
want it sorted out within a week. But yes it was quite along time to wait and its very 
difficult to put to the back of your mind knowing that you have got this appointment and 
you start to feel anxious, you want to be seen sooner rather than later because you are so 
XQVXUHRIZKDWLWLV´ :RPDQLQ¶VZDLWLQJIRUURXWLQHDSSRLQWPHQW 
³, PHDQ WKH ORQJHU \RX OHDYH LW WKH ZRUVH LW¶V JRLQJ WR JHW DQG LW FDQ VSUHDG WR RWKHU
RUJDQVFDQ¶WLW´:RPDQLQ¶VZLWKQHJDWLYHGLDJQRVLV 
 
Waiting for Results  
Waiting for the results of investigations to determine whether they have breast cancer has 
been described as being a very stressful time for women (Fridfinnsdottir 1997, Poole and 
Lyne 2000). In the current study women reported that they were reassured after the initial 
consultation with the doctor but subsequently became anxious again whilst waiting for 
the results of tests. 
³6RQR,IHOWYHU\UHDVVXUHGE\WKDW,GLGQ¶WIHHOUHDVVXUHGVXEVHTXHQWO\EHFDXVH
it took along time to get the results and I was getting DELWZRUNHGXS´ 
:RPDQLQ¶VZLWKQHJDWLYHGLDJQRVLV 
 
This anxiety may be due to fear of the unknown, not only the possibility of a life 
threatening disease in terms of mortality but also the threat to life as one knows it with 
the possible attendance at hospital for surgery, and follow up appointments for 
radiotherapy and chemotherapy. 
 
³EHFDXVH WKHZRUVWELW LV WKH IHDURI WKHXQNQRZQDQGZKHQ\RXGRQ¶W NQRZ
ZKDW \RX¶YH JRW $W OHDVW ZKHQ \RX NQRZ ZKDW \RX¶YH JRW \RX NQRZ ZKDW \RX DUH XS
against. But I think it is the fear of the unknown so that space of time there is quite 




The aim of the study was to look at delay in the diagnosis and treatment of breast cancer. 
As it was designed, the study was realistic to study delay in the referral, diagnosis, and 
discharge of those with a negative diagnosis. However because of the sample size it is 
difficult to draw quantifiable conclusions about delay in the treatment of breast cancer, 
although the interview data suggest that the main causes of delay in treatment are waiting 
for surgery and waiting for radiotherapy post surgery. The study was large for a lone 
researcher and the data collection took one year to complete partly because of difficulty 
in establishing access to one of the research sites. Collecting the survey data was often 
difficult particularly when patients were seen at peripheral hospitals for follow up 
appointments. Recruitment of patients for interview was slow and the interviews 
themselves were time-consuming because of the often long distances to travel. The 
lessons learnt from the study include: the need when carrying out this sort of research to 
negotiate access with all the staff involved to ensure co-operation, and to make notes as 
soon as possible after observational study to ensure detail is not lost. 
 
10. Conclusions 
Variations in the process of care between sites appear to be linked to the availability of 
imaging facilities and the staff. At all the sites these appeared to be the limiting factors in 
the number of patients who could be either seen in any one clinic or in how long it took to 
receive a diagnosis. Where the prioritising of letters takes place it appears to cause 
patients who are referred routinely to wait longer for appointments than at places where 
no prioritising takes place. The method in which patients receive a negative diagnosis 
could be reviewed to save unnecessary follow up appointments. 
It appears from both observation and from interviews with the staff that there is a 
shortage of radiologists specialising in breast imaging with a need for professionals 
competent to perform breast ultrasound, and image guided procedures. Further study may 
be useful to look at an alternative skill mix to facilitate the speedy diagnosis of breast 
cancers.  
11.Future career plans 
After completing my thesis I would hope to continue in health services research. To fulfil 
this aim I propose to submit a proposal to the Regional Small Grants Scheme. 
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Fig 9 Diagnosis to Start of Appropriate 
Treatment or Discharge

































Fig 10 Diagnosis to Start of Appropriate










Fig 11 Diagnosis to Start of Appropriate














Fig 12 Diagnosis to Start of Appropriate

































 Fig. 5  Attendance to Diagnosis














Fig. 6 Time from attendance to diagnosis














Fig 7 Time from attendance to diagnosis






























Fig 8 Time from attendance to diagnosis
Site C:  Bar 1=72 cases
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